Understanding the Market | HYGEIA HEALTH rises over 8% as founder Zhu Yiwen increases holdings by 1.6648 million shares
HYGEIA HEALTH's stock price rose by over 8%, with an increase of 8.14% as of the time of publication, trading at HKD 14.88, with a transaction volume of HKD 339 million. Founder Zhu Yiwen increased his holdings by 1.6648 million shares on September 18, bringing his ownership stake to 46.28%. Although a decline in performance is expected in the first half of 2025, the company's balance sheet shows positive signals, and it is anticipated that it will gradually emerge from the trough in 2026
According to the Zhitong Finance APP, HYGEIA HEALTH (06078) has risen over 8%, currently up 8.14% at HKD 14.88, with a transaction volume of HKD 339 million.
On the news front, the latest data from the Hong Kong Stock Exchange shows that on September 18, HYGEIA HEALTH's founder, controlling shareholder, chairman, and CEO Zhu Yiwen increased his holdings by 1.6648 million shares at a price of HKD 13.8284 per share, totaling approximately HKD 23.0215 million. After the increase, the latest number of shares held is approximately 286 million, with a latest holding ratio of 46.28%. The company stated that since its listing, Zhu Yiwen has never reduced his holdings in the company's stock and has increased his holdings in the secondary market 22 times.
Recent research reports from Zhongtai International pointed out that although the company's performance is expected to decline in the first half of 2025, there are positive signals emerging in the balance sheet: 1) Accounts receivable decreased by 9.1% compared to the end of last year, indicating an improvement in the collection situation of its hospitals. 2) Net cash from operating activities increased by 29.9% year-on-year, as the company actively reduced capital expenditures, with capital expenditures in the first half of the year decreasing by 28.5% year-on-year, and cash increased by HKD 240 million compared to the end of last year, with the net debt ratio decreasing by 6.7 percentage points. The bank stated that the company's balance sheet is improving, and the government has repeatedly introduced policies to support the pharmaceutical and medical services industry, believing that the company is expected to gradually emerge from the trough starting in 2026
